IL41666A - Substituted 4,5-dihydropyridines,their production and pharmaceutical compositions containing them - Google Patents

Substituted 4,5-dihydropyridines,their production and pharmaceutical compositions containing them

Info

Publication number
IL41666A
IL41666A IL41666A IL4166673A IL41666A IL 41666 A IL41666 A IL 41666A IL 41666 A IL41666 A IL 41666A IL 4166673 A IL4166673 A IL 4166673A IL 41666 A IL41666 A IL 41666A
Authority
IL
Israel
Prior art keywords
compound
hereinbefore described
compounds
general formula
compound according
Prior art date
Application number
IL41666A
Other languages
English (en)
Other versions
IL41666A0 (en
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2210650A external-priority patent/DE2210650C3/de
Priority claimed from DE19722260860 external-priority patent/DE2260860A1/de
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of IL41666A0 publication Critical patent/IL41666A0/xx
Publication of IL41666A publication Critical patent/IL41666A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pulmonology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Medicinal Preparation (AREA)
IL41666A 1972-03-06 1973-03-02 Substituted 4,5-dihydropyridines,their production and pharmaceutical compositions containing them IL41666A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2210650A DE2210650C3 (de) 1972-03-06 1972-03-06 2-Amino-6-alkoxy-4,5-dihydropyridin-3,5-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel
DE19722260860 DE2260860A1 (de) 1972-12-13 1972-12-13 Verfahren zur herstellung von neuen 2-amino-6-alkylmercapto-4,5-dihydropyridinen sowie ihre verwendung als antihypertensiva

Publications (2)

Publication Number Publication Date
IL41666A0 IL41666A0 (en) 1973-05-31
IL41666A true IL41666A (en) 1976-02-29

Family

ID=25762843

Family Applications (1)

Application Number Title Priority Date Filing Date
IL41666A IL41666A (en) 1972-03-06 1973-03-02 Substituted 4,5-dihydropyridines,their production and pharmaceutical compositions containing them

Country Status (16)

Country Link
US (1) US3876646A (da)
JP (1) JPS5626658B2 (da)
AT (1) AT325614B (da)
CA (1) CA985685A (da)
CH (1) CH580591A5 (da)
CS (1) CS179980B2 (da)
DD (1) DD106832A5 (da)
DK (1) DK135714C (da)
ES (1) ES412320A1 (da)
FR (1) FR2183673B1 (da)
GB (1) GB1374551A (da)
HU (1) HU167088B (da)
IE (1) IE37367B1 (da)
IL (1) IL41666A (da)
NL (1) NL7303134A (da)
SE (1) SE384206B (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3951993A (en) * 1972-03-06 1976-04-20 Bayer Aktiengesellschaft 2-Amino-4,5-dihydropyridine derivatives and process for their preparation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1923990C3 (de) * 1969-05-10 1978-11-23 Bayer Ag Verfahren zur Herstellung von N-substituierten M-Dihydropyridin-S.S-dicarbonsäureestern
DE2013431C3 (de) * 1970-03-20 1979-12-20 Bayer Ag, 5090 Leverkusen 4-Azidophenyl-l,4-dihydropyridin-3,5-dicarbonsäureester
DE1963186C3 (de) * 1969-12-17 1979-02-15 Bayer Ag, 5090 Leverkusen Schwefelhaltige 1,4-Dihydropyridin-33-dicarbonsäureester
DE2003146A1 (de) * 1970-01-24 1971-07-29 Bayer Ag Neue 1,4-Dihydropyridinderivate
DE2117571C3 (de) * 1971-04-10 1979-10-11 Bayer Ag, 5090 Leverkusen Unsymmetrische 1,4-Dihydropyridin-33-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
DE2117572C3 (de) * 1971-04-10 1980-03-20 Bayer Ag, 5090 Leverkusen Unsymmetrische 1,4-Dihydropyridin ^-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel

Also Published As

Publication number Publication date
NL7303134A (da) 1973-09-10
AT325614B (de) 1975-10-27
IE37367L (en) 1973-09-06
ATA196973A (de) 1975-01-15
DK135714C (da) 1977-11-14
ES412320A1 (es) 1976-04-16
CA985685A (en) 1976-03-16
US3876646A (en) 1975-04-08
SE384206B (sv) 1976-04-26
IE37367B1 (en) 1977-07-06
GB1374551A (en) 1974-11-20
HU167088B (da) 1975-08-28
DK135714B (da) 1977-06-13
CS179980B2 (en) 1977-12-30
FR2183673B1 (da) 1976-12-03
FR2183673A1 (da) 1973-12-21
JPS5626658B2 (da) 1981-06-19
CH580591A5 (da) 1976-10-15
JPS4899180A (da) 1973-12-15
DD106832A5 (da) 1974-07-05
IL41666A0 (en) 1973-05-31

Similar Documents

Publication Publication Date Title
CA1064496A (en) Preparation of a new cincamine salt and compound thus obtained
US3826836A (en) Phenyl-imidazolyl-fatty acid derivatives for treating mycotic infections
GB1234058A (da)
IL41669A (en) Condensed pyridine compounds their production and pharmaceutical compositions containing them
JPS56128767A (en) Substituted imidazole derivative, its manufacture and medicine as effective component
US5002949A (en) 5-substituted-6-aminopyrimidine derivatives
CH627465A5 (de) Verfahren zur herstellung von benzisothiazolonen.
IL43079A (en) 2-amino-1,4-dihydropyridines,their production and pharmaceutical compositions containing them
IE44737B1 (en) Bis-quaternary pyridinum-2-aldoxime salts and process for their preparation
US4590205A (en) Antiinflammatory and/or analgesic 2,3-diaryl-5-halo thiophenes
GB1107470A (en) Basic esters and a process for their production
JPH01193219A (ja) 赤血球凝固阻止作用を有する医薬
US2844510A (en) Phosphoric acid derivatives of 1-phenyl-2, 3-dimethyl-4-amino-5-pyrazolone
EP0087629A2 (en) Antiinflammatory and/or analgesic 2,3-Diaryl-5-halo thiophenes
CA1246065A (en) 5-(3,4-dihydrocarbostyril-6-yl)-3,6-dihydro-1,2,4- thiadiazin-2-one
KR950001040B1 (ko) 티오우레아 유도체 및 이를 함유하는 항균제 및 항궤양제
IL41666A (en) Substituted 4,5-dihydropyridines,their production and pharmaceutical compositions containing them
US4256752A (en) Treatment of ulcers with acylated aminoalkyl cyanoguanidines containing a heterocyclic residue
IL43063A (en) 2-phenoxy-1-imidazolyl-alkan-3-ones their production and pharmaceutical compositions containing them
IL41664A (en) 2,6-Diamino-dihydropyridines and their pharmaceutical preparations
IL42745A (en) 2-amino-4-h-pyrane derivatives,their production and pharmaceutical compositions containing them
US3103517A (en) Z-tfflazolyl
IL30706A (en) 2-halomethyl-3-carbamoyl quinoxaline-1,4-di-n-oxides
US3829422A (en) 1,4-substituted-pyrimidin-2(1h)-ones
US3725419A (en) Quinuclidylalkyl esters